Trial Profile
Exploratory study of apatinib for advanced colorectal cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Sep 2018
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Irinotecan (Primary) ; Rivoceranib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 03 Sep 2018 New trial record